Tolerability of anastrozole (A) compared with tamoxifen (T): Mature data in the adjuvant setting - Data reported on behalf of the ATAC ('arimidex', tamoxifen, alone or in combination) trialists' group

被引：0

作者：

Mansel, Robert ^{[1
]}

机构：

[1] Univ Wales Hosp, Dept Surg, Cardiff, Wales

来源：

ANNALS OF ONCOLOGY | 2006年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：94 / 94

页数：1

共 50 条

[31] The anastrozole, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial in post-menopausal women: Regional variations in surgical practice in patients recruited into the trial. The ATAC Trialists' Group.
Sainsbury, R
ANNALS OF ONCOLOGY, 2000, 11 : 20 - 20
[32] Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
Howell, A
Cuzick, J
Baum, M
Buzdar, A
Dowsett, M
Forbes, JF
Hoctin-Boes, G
Houghton, I
Locker, GY
Tobias, JS
LANCET, 2005, 365 (9453): : 60 - 62
[33] Analysis of fracture risk factors from the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial: 5-year data.
Howell, A.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 18S - 18S
[34] Effect of anastrozole on bone mineral density: 5-year results from the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial.
Coleman, R. E.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 5S - 5S
[35] The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy
Duffy, S
Jackson, TL
Lansdown, M
Philips, K
Wells, M
Pollard, S
Clack, G
Coibion, M
Bianco, AR
HUMAN REPRODUCTION, 2005, 20 (01) : 294 - 301
[36] The anastrozole, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial in post-menopausal women: Regional variation in knowledge of hormone receptor status prior to randomisation into the trial. The ATAC Trialists' Group.
Howell, A
ANNALS OF ONCOLOGY, 2000, 11 : 20 - 20
[37] Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial
Mansel, R.
Locker, G.
Fallowfield, L.
Benedict, A.
Jones, D.
BRITISH JOURNAL OF CANCER, 2007, 97 (02) : 152 - 161
[38] Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen alone or in combination) trial
R Mansel
G Locker
L Fallowfield
Á Benedict
D Jones
British Journal of Cancer, 2007, 97 : 152 - 161
[39] Impact of adjuvant chemotherapy prior to endocrine therapy: 68 month results from the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial.
Buzdar, AU
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 30S - 30S
[40] Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial (vol 359, pg 2131, 2002)
Fodor, J
Borrego, MR
LANCET, 2002, 360 (9344): : 1520 - 1520

← 1 2 3 4 5 →